The global antisense oligonucleotides market is set to experience robust growth, with revenues projected to surge to USD 5,519.6 million by 2033, up from USD 2,913.5 million in 2023. This marks a compound annual growth rate (CAGR) of 6.6% over the forecast period. Adoption trends for antisense oligonucleotides are being strongly influenced by their promising potential in treating a wide range of medical …